Xianjing Feng Selected Research

carbazic acid

9/2021

Carbazate-modified cross-linked dextran microparticles suppress the progression of osteoarthritis by ROS scavenging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianjing Feng Research Topics

Disease

7	Ischemic Stroke 01/2021 - 01/2019
4	Stroke (Strokes) 01/2021 - 01/2019
4	Pathologic Constriction (Stenosis) 01/2021 - 01/2019
1	Neoplasms (Cancer) 07/2022
1	Hyperglycemia 01/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Inflammation (Inflammations) 09/2021
1	Osteoarthritis 09/2021
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Atherosclerosis 05/2020
1	Coronary Disease (Coronary Heart Disease) 01/2019

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	phenylacetylglutamineIBA 01/2021 - 01/2021
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Insulin ReceptorIBA 01/2022
1	carbazic acidIBA 09/2021
1	Dextrans (Dextran)FDA Link 09/2021
1	Polysaccharides (Glycans)IBA 09/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	BilirubinIBA 01/2021
1	AMP-Activated Protein KinasesIBA 05/2020
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 07/2019
1	AdipokinesIBA 01/2019
1	ApelinIBA 01/2019

Therapy/Procedure

2	Therapeutics 07/2022 - 01/2021
1	Play Therapy (Therapy, Play) 07/2022
1	Drug Therapy (Chemotherapy) 07/2022
1	Immunotherapy 07/2022